![Kevin Sin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Kevin Sin worked as a Vice President at Tesaro, Inc. and as SVP & Head-Worldwide Business Development at GSK Plc from 2018 to 2022.
Eerdere bekende functies van Kevin Sin
Bedrijven | Functie | Einde |
---|---|---|
GSK PLC | Corporate Officer/Principal | 01-01-2022 |
TESARO INC | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GSK PLC | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Tesaro, Inc.
![]() Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |